Kerala’s AMR Crisis: Rising Drug Resistance Threatens Public Health in 2025

23 Sep Kerala’s AMR Crisis: Rising Drug Resistance Threatens Public Health in 2025

✎ Antimicrobial Resistance (AMR) is the evolutionary adaptation of microorganisms to survive antimicrobial treatments, driven by overuse/misuse of antibiotics, and poses a systemic threat to global public health by undermining…

Subject Relevance — Where This Topic Fits

• GS Paper II — Governance, Transparency and Accountability (Health Governance)  |  GS Paper III — Science and Technology (Health and Environment)  |  GS Paper III — Challenges to Development (Public Health and Epidemiology)
• Prelims: Antimicrobial Resistance (AMR), Extended-Spectrum Beta-Lactamases (ESBL), Carbapenem-resistant Enterobacteriaceae (CRE), Methicillin-Resistant Staphylococcus aureus (MRSA), Kerala Antimicrobial Resistance Surveillance Network (KARS-Net), National Action Plan on Antimicrobial Resistance (NAP-AMR), One Health Approach, Antibiogram, Nosocomial Infections, Community-Acquired Infections
• Essay: The Intersection of Public Health and Sustainable Development: Addressing Antimicrobial Resistance in the 21st Century, Science, Ethics, and Governance: Balancing Innovation and Responsibility in Combating Antimicrobial Resistance

Quick Revision: Antimicrobial Resistance (AMR) is the evolutionary adaptation of microorganisms to survive antimicrobial treatments, driven by overuse/misuse of antibiotics, and poses a systemic threat to global public health by undermining modern medicine’s capacity to treat infections.

Why is this in the news?

The release of the Kerala Antimicrobial Resistance Surveillance Network (KARS-Net) antibiogram for 2025 has brought into sharp focus the alarming escalation of antimicrobial resistance (AMR) in Kerala. This development underscores the urgent need for a multi-sectoral, evidence-based response to avert a post-antibiotic era in the state.

Background

• Antimicrobial resistance (AMR) is a global public health crisis recognised by the World Health Organization (WHO) as one of the top 10 threats to humanity, with projections indicating up to 10 million annual deaths by 2050 if unchecked.
• India, as a major consumer of antibiotics, contributes significantly to the global AMR burden, with studies indicating that 58,000 newborn deaths annually are attributable to sepsis caused by resistant pathogens.
• Kerala, with its high healthcare accessibility and dense population, serves as a critical sentinel state for monitoring AMR trends in India, with the Kerala Antimicrobial Resistance Surveillance Network (KARS-Net) established in 2019 under the Kerala Antimicrobial Resistance Strategic Action Plan (KARSAP).
• The National Action Plan on Antimicrobial Resistance (NAP-AMR) 2017–2021, developed by the Ministry of Health and Family Welfare, outlines a comprehensive framework for AMR containment, emphasising surveillance, infection prevention, rational antibiotic use, and research.
• The ‘One Health’ approach, integrating human, animal, and environmental health sectors, has been increasingly adopted globally to address AMR, recognising the interconnectedness of antimicrobial use across these domains.
• Kerala’s healthcare system, with its high density of tertiary care institutions and widespread antibiotic use, faces unique challenges in AMR containment, including over-the-counter antibiotic sales and suboptimal infection control practices.

What is Antimicrobial Resistance (AMR)?

• Antimicrobial Resistance (AMR) is the ability of microorganisms (bacteria, viruses, fungi, and parasites) to survive and proliferate despite exposure to antimicrobial agents designed to kill or inhibit their growth.
• AMR arises primarily through the overuse or misuse of antimicrobials in human medicine, veterinary practice, and agriculture, accelerating the selection of resistant strains.
• The phenomenon is exacerbated by horizontal gene transfer, where resistant genes are shared between different bacterial species, facilitating the spread of resistance across diverse pathogens.
• AMR is classified into two broad categories: intrinsic resistance (natural genetic traits of a microorganism) and acquired resistance (developed through mutations or acquisition of resistance genes).
• Key mechanisms of AMR include enzymatic degradation of antibiotics (e.g., beta-lactamases), alteration of antibiotic targets, reduced permeability of bacterial cell walls, and active efflux of antibiotics from bacterial cells.
• The consequences of AMR are severe, including prolonged illness, increased mortality, higher healthcare costs, and the emergence of untreatable infections, particularly in vulnerable populations such as neonates, the elderly, and immunocompromised individuals.
• AMR is recognised as a ‘silent pandemic’ due to its gradual but insidious progression, with the World Bank estimating that global GDP could decline by 3.8% by 2050 in a high-AMR scenario.
• The WHO’s Global Antimicrobial Resistance Surveillance System (GLASS) and India’s National Centre for Disease Control (NCDC) play pivotal roles in monitoring and reporting AMR trends globally and nationally.

Key Features

Feature	Significance
Kerala Antimicrobial Resistance Surveillance Network (KARS-Net)	A state-level surveillance system coordinated by the Department of Microbiology, Government Medical College, Thiruvananthapuram, under the Kerala Antimicrobial Resistance Strategic Action Plan (KARSAP), monitoring AMR trends across 59 institutions and 55 laboratories in 14 districts.
Antibiogram 2025	A comprehensive report analysing 65,849 unique-patient isolates of nine priority pathogens, providing granular data on resistance patterns in Gram-negative and Gram-positive bacteria across in-patients, outpatients, and ICU settings.
Extended-Spectrum Beta-Lactamase (ESBL) production	A critical resistance mechanism in Gram-negative bacteria (e.g., E. coli, Klebsiella) that renders common penicillin and cephalosporin antibiotics ineffective, observed in 73% of E. coli and 68% of Klebsiella blood isolates.
Carbapenem resistance	A ‘last-resort’ antibiotic class showing alarming resistance rates: 8% in E. coli, 43% in Klebsiella, and 52% in Acinetobacter blood isolates, severely limiting treatment options for severe infections.
Methicillin-resistant Staphylococcus aureus (MRSA)	A Gram-positive pathogen exhibiting 33% resistance in blood isolates, indicating the persistence and spread of multidrug-resistant infections in both hospital and community settings.

Why it Matters

Public Health Impact

• The transition of AMR from a hospital-centric issue to a community-wide challenge, with resistant pathogens like Shigella now prevalent outside healthcare settings, complicates infection control and treatment protocols.
• High resistance rates in ICU pathogens (e.g., Acinetobacter, Pseudomonas) threaten the viability of critical care interventions, increasing mortality and healthcare costs.
• The dominance of Gram-negative bacteria (E. coli, Klebsiella) in resistance profiles underscores the need for targeted interventions, as these organisms are major causes of bloodstream and urinary tract infections.

Healthcare System Burden

• AMR imposes significant financial strain on Kerala’s healthcare system, with prolonged hospital stays, increased use of last-line antibiotics, and higher mortality rates driving up treatment costs.
• The reliance on Carbapenems and other reserve antibiotics accelerates resistance development, creating a feedback loop that reduces the efficacy of existing treatment regimens.
• Surveillance data from KARS-Net enables evidence-based policy formulation, but the scale of resistance necessitates urgent scaling of diagnostic and therapeutic infrastructure.

Economic Implications

• AMR-related morbidity and mortality reduce workforce productivity, particularly in sectors with high physical labour demand, indirectly impacting Kerala’s economy.
• The economic burden extends to households, where out-of-pocket expenditure on prolonged treatments and secondary complications strains family finances.
• Long-term costs include the need for investment in antimicrobial stewardship programs, rapid diagnostic tools, and research into novel antibiotics or alternatives.

Global Health Alignment

• Kerala’s AMR surveillance aligns with the World Health Organization’s Global Antimicrobial Resistance Surveillance System (GLASS), contributing to a broader understanding of resistance trends in low- and middle-income countries.
• The state’s data can inform national policies under the National Action Plan on Antimicrobial Resistance (NAP-AMR), ensuring local evidence supports broader public health strategies.

Challenges

1. Rising Carbapenem Resistance

• Carbapenem-resistant Enterobacteriaceae (CRE) and Acinetobacter pose a severe threat due to their high resistance rates (43% in Klebsiella, 52% in Acinetobacter) and limited treatment options.
• The spread of Carbapenem resistance is exacerbated by the overuse of broad-spectrum antibiotics in both clinical and agricultural settings, necessitating strict stewardship measures.
• Healthcare-associated outbreaks of Carbapenem-resistant organisms can lead to prolonged ICU stays and high mortality, particularly in immunocompromised patients.

UPSC Link: GS3: Science & Tech – Health

2. Community-Acquired AMR

• The emergence of resistant pathogens like Shigella in community settings indicates that AMR is no longer confined to hospitals, complicating public health interventions and requiring community-level surveillance.
• Self-medication and over-the-counter antibiotic sales in Kerala’s informal healthcare sector contribute to the selection pressure driving resistance in community-acquired infections.
• Lack of awareness among the public about the dangers of inappropriate antibiotic use hinders efforts to curb resistance at the grassroots level.

UPSC Link: GS2: Health – Public Health

3. Diagnostic and Therapeutic Gaps

• Delayed or inadequate laboratory capacity for susceptibility testing delays appropriate treatment, increasing the risk of resistance development and patient deterioration.
• Limited availability of rapid diagnostic tools in peripheral healthcare facilities restricts timely identification of resistant pathogens, particularly in rural areas.
• The absence of standardized antibiotic prescribing guidelines in primary care settings leads to empirical overuse of broad-spectrum antibiotics.

UPSC Link: GS3: Science & Tech – Health Innovation

4. One Health Interface

• AMR in Kerala is influenced by interactions between human, animal, and environmental health, with antibiotic use in livestock and agriculture contributing to resistance in human pathogens.
• Poor waste management and sewage disposal in urban and rural areas facilitate the environmental spread of resistant bacteria, creating reservoirs that re-infect humans.
• Integrated surveillance across human, animal, and environmental sectors is essential but currently underdeveloped in Kerala’s AMR response.

UPSC Link: GS3: Environment – One Health Approach

5. Policy Implementation Gaps

• Despite the Kerala Antimicrobial Resistance Strategic Action Plan (KARSAP), enforcement of regulations on antibiotic sales, prescription practices, and infection control remains inconsistent.
• Inadequate funding for AMR surveillance and stewardship programs limits their scalability and effectiveness, particularly in private healthcare institutions.
• Lack of coordination between state, district, and local health authorities hampers the implementation of integrated AMR control strategies.

UPSC Link: GS2: Governance – Policy Implementation

Challenges — UPSC Perspective

Issue	Concern
Carbapenem resistance in Klebsiella	43% of blood isolates are resistant, severely limiting treatment options for severe infections like sepsis and pneumonia.
ESBL-producing E. coli in community settings	73% of isolates produce ESBL, rendering common antibiotics ineffective and increasing reliance on last-line drugs.
MRSA in bloodstream infections	33% resistance rate indicates persistent circulation of multidrug-resistant Gram-positive pathogens in hospitals and communities.
Limited rapid diagnostic infrastructure	Delayed susceptibility testing delays appropriate treatment, exacerbating resistance and patient outcomes.
Antibiotic overuse in agriculture	Unregulated use in livestock contributes to environmental reservoirs of resistance, complicating human health interventions.

Way Forward

• Strengthen antimicrobial stewardship programs in hospitals by enforcing prescription audits, restricting last-line antibiotic use, and promoting culture-guided therapy.
• Expand KARS-Net’s surveillance to include rapid diagnostic tools and real-time data sharing across public and private healthcare institutions.
• Launch community awareness campaigns to educate the public on the risks of self-medication and the importance of completing antibiotic courses.
• Implement One Health surveillance by integrating data from human, animal, and environmental sectors to identify and mitigate resistance hotspots.
• Enforce stricter regulations on over-the-counter antibiotic sales and promote the use of rapid diagnostic kits in pharmacies and primary health centres.
• Invest in research and development of novel antibiotics, phage therapy, and alternative treatments to address the dwindling efficacy of existing drugs.
• Develop standardized antibiotic prescribing guidelines for primary care providers and ensure their dissemination through continuous medical education programs.

UPSC Value Addition

Prelims Practice Questions

Q1. Consider the following statements regarding Antimicrobial Resistance (AMR):
1. AMR occurs when bacteria, viruses, fungi, and parasites no longer respond to antimicrobial medicines.
2. The Kerala Antimicrobial Resistance Surveillance Network (KARS-Net) is coordinated by the Indian Council of Medical Research (ICMR).
3. Extended-Spectrum Beta-Lactamases (ESBL) are enzymes that confer resistance to common penicillin and cephalosporin antibiotics.
4. Carbapenems are considered a first-line treatment for most bacterial infections.
How many of the above statements are correct?

1. Only one
2. Only two
3. Only three
4. All

Answer: Only three — Statements 1 and 3 are correct. Statement 2 is incorrect as KARS-Net is coordinated by the Department of Microbiology at Government Medical College, Thiruvananthapuram, under the Kerala Antimicrobial Resistance Strategic Action Plan (KARSAP). Statement 4 is incorrect as Carbapenems are reserved as last-resort antibiotics due to their critical role in treating multidrug-resistant infections.

Q2. Assertion (A): The rise of Carbapenem-resistant Enterobacteriaceae (CRE) is a significant public health concern in Kerala.
Reason (R): Carbapenems are broad-spectrum antibiotics used as a last line of defence against multidrug-resistant bacterial infections.

1. Both A and R are true, and R is the correct explanation of A
2. Both A and R are true, but R is not the correct explanation of A
3. A is true, but R is false
4. A is false, but R is true

Answer: Both A and R are true, and R is the correct explanation of A — Both the assertion and reason are correct. Carbapenem-resistant Enterobacteriaceae (CRE) are a critical concern due to their resistance to last-resort antibiotics, making infections difficult to treat. The reason correctly explains the assertion.

Q3. Match the following pathogens with their corresponding resistance mechanisms:

Column I (Pathogen) Column II (Resistance Mechanism)
A. Escherichia coli 1. Production of Extended-Spectrum Beta-Lactamases (ESBL)
B. Staphylococcus aureus 2. Methicillin resistance (MRSA)
C. Klebsiella pneumoniae 3. Carbapenem resistance
D. Pseudomonas aeruginosa 4. Multidrug resistance due to efflux pumps

1. A-1, B-2, C-3, D-4; A-3, B-2, C-1, D-4; A-2, B-1, C-3, D-4; A-4, B-2, C-1, D-3
2. answer_explain_match_pairs_exact
3. answer_explain_match_pairs_exact

Answer: ? — Escherichia coli frequently produces ESBL enzymes (A-1). Staphylococcus aureus exhibits methicillin resistance (MRSA) (B-2). Klebsiella pneumoniae shows high rates of carbapenem resistance (C-3). Pseudomonas aeruginosa often displays multidrug resistance via efflux pumps (D-4).

Mains Practice Question

✍ Antimicrobial Resistance (AMR) has emerged as a critical public health challenge in India, with Kerala’s latest antibiogram data revealing alarming resistance patterns across both hospital and community settings. Critically examine the factors contributing to the rise of AMR in Kerala, and outline the institutional mechanisms—both at the state and national levels—that are being deployed to combat this menace. (15 Marks)

Approach: MODEL-ANSWER SKELETON:

1. **Introduction (2 marks)**: Define AMR and its significance in the context of Kerala’s 2025 antibiogram data. Highlight the gravity of resistance in Gram-negative pathogens (E. coli, Klebsiella, Pseudomonas) and Gram-positive pathogens (MRSA, Enterococcus).

2. **Factors Contributing to AMR in Kerala (6 marks)**:
– **Overuse and Misuse of Antibiotics**: Discuss irrational prescription practices, self-medication, and over-the-counter availability of antibiotics.
– **Agricultural and Livestock Practices**: Highlight the role of antibiotic use in poultry, aquaculture, and agriculture as a reservoir for resistant bacteria.
– **Healthcare-Associated Infections (HAIs)**: Poor infection control practices in hospitals, inadequate hand hygiene, and suboptimal sterilization.
– **Lack of Surveillance and Data Gaps**: Incomplete reporting and fragmented surveillance systems prior to KARS-Net.
– **Limited Public Awareness**: Low awareness among patients and healthcare providers about AMR and its consequences.

3. **Institutional Mechanisms to Combat AMR (5 marks)**:
– **State-Level Initiatives**:
– Kerala Antimicrobial Resistance Surveillance Network (KARS-Net): Its structure, coverage (59 institutions, 55 labs, 14 districts), and data-driven approach.
– Kerala Antimicrobial Resistance Strategic Action Plan (KARSAP): Key objectives, including antimicrobial stewardship, infection prevention, and public awareness.
– **National-Level Frameworks**:
– National Action Plan on Antimicrobial Resistance (NAP-AMR) 2017-2021: Its five strategic priorities (awareness, surveillance, infection control, rational use, and research).
– Indian Council of Medical Research (ICMR) AMR Surveillance Network: Role in standardizing surveillance and guiding policy.
– National Centre for Disease Control (NCDC): Coordination of AMR containment efforts.
– **Global Collaborations**: WHO’s Global Action Plan on AMR and India’s alignment with international commitments.

4. **Challenges and Way Forward (2 marks)**:
– Discuss gaps in implementation, such as enforcement of prescription regulations, lack of antimicrobial stewardship programs in smaller hospitals, and the need for intersectoral coordination (One Health approach).
– Emphasize the importance of public-private partnerships, research into new antibiotics, and strengthening of primary healthcare to reduce antibiotic misuse.

Source: The Hindu

---

Generated by AanyaAi for educational purpose.

---

Related guides on our sites

• Best PSIR optional coaching for upsc
• Best economics optional coaching for upsc
• Best PSIR optional teacher for upsc
• Best teacher of PSIR optional for upsc